Recent advances in the epidemiology, diagnosis, and management of Trichomonas vaginalis infection.
Olivia T Van GerwenChristina Ann MuznyPublished in: F1000Research (2019)
Trichomonas vaginalis is the most common, curable non-viral sexually transmitted infection (STI) worldwide. Despite this burden of disease, it is not currently a reportable disease in the United States. Recent advances in the epidemiology, diagnosis, and management of T. vaginalis infection are described in this article. This includes updated global and U.S. prevalence data in women and men as well as recent epidemiological data in HIV-infected individuals and pregnant women. Advances in molecular diagnostics are also reviewed, as are data from recent clinical trials regarding the treatment of trichomonas in women.
Keyphrases
- pregnant women
- hiv infected
- electronic health record
- clinical trial
- risk factors
- polycystic ovary syndrome
- big data
- pregnancy outcomes
- sars cov
- antiretroviral therapy
- machine learning
- human immunodeficiency virus
- randomized controlled trial
- artificial intelligence
- open label
- phase ii
- breast cancer risk
- single molecule
- skeletal muscle